GIIDS - GI Inflammatory Diseases Summit is organized by Hanson Wade and will be held from Jun 24 - 26, 2019 at Revere Hotel Boston Common, Boston, Massachusetts, United States of America.
Delivering higher rates of clinical remission, demonstrating more gut-selective pharmacology and minimizing adverse side effects of your IBD candidate Developed in combination with 20 stakeholders including AbbVie, Theravance and Genentech: GIIDS will be the first end-to-end drug development forum focused exclusively on delivering more clinically safe and efficacious treatments for patients suffering from chronic GI inflammation.
Attend this focused, discussion orientated forum to:
• Hear case-studies showcasing the safety and efficacy of antigen-specific, microbiome based, anti-inflammatory and small molecule candidates to better align your own research with the pace and direction of the rest of the field
• Understand the latest advancements in molecular profiling, precision medicine and pharmacodynamic biomarkers to better demonstrate efficacy in the clinic
• Equip yourself with strategies to optimize clinical trial success in a hypercompetitive patient recruitment landscape to more efficiently translate success through the clinic
Regulation of Colon Inflammation by Regulatory T-Cells, Microbiota & Bile Acid Metabolism
Description: Bacterial metabolism of bile acids is mechanistically linked to genotoxic and inflammatory process that predispose to IBD and colorectal cancer (CRC). Bile acid metabolizing bacteria are also responsible for the extrathymic generation of regulatory T-cells, the rate limiting factors in the control of colon inflammation. Deregulation of inflammation involves epigenetic and gene expression changes that take place in gut infiltrating regulating T-cells. Understanding the interface of gut microbiota and Treg function in the gut will critically help in designing effective preventive and therapeutic strategies.
Join these experts as they present in detail on:
• Treg diversity and function in colon cancer
• Molecular pathways that regulate Treg functions and Treg/Th17 balance
• Microbial sulfur metabolism and colorectal cancer risk
• Genetics of bile acid metabolism and colorectal cancer risk
|Contact No. :||+16174554188
May 31, 2019
|Registration Type||End Date||Price|
|Conference 1 Workshop - Standard Fee||23 Jun,2019||USD 3498.00|
|Conference Only - Standard Fee||23 Jun,2019||USD 2899.00|
|Workshop Only Fee||23 Jun,2019||USD 699.00|